PEP trades against a final fair-value range of $142.66-$206.45, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $143, high $206, with mid-point at $174.
لم تتم ترجمة هذا التقرير بعد. قم بالتحديث خلال بضع دقائق بمجرد أن تلحق قائمة انتظار الترجمة بالركب.
§1 الملخص التنفيذي
Composite fair value $174 with high case $206.
Implied upside of 12.8% to fair value.
Moat 9/10 · confidence 88/100 · Mature dividend.
Trades at a measured discount to fair value with adequate margin of safety.
Fair value
$174
Margin of safety
+11.3%
Confidence
88/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$154.62Price
FV $174.41
High $206.45
PEP trades against a final fair-value range of $142.66-$206.45, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Deep global distribution networks covering
Deep global distribution networks covering developed and emerging markets.
Immense brand equity and pricing
Immense brand equity and pricing power across both beverage and snack portfolios.
Bull thesis
Valuation synthesis intentionally anchors heavily on Forward Earnings to mitigate terminal value dominance.
§2 السيناريو الهبوطي
A sustained macroeconomic downturn coupled with accelerated adoption of GLP-1 weight-loss drugs leads to structural volume declines and an inability to offset cost inflation through pricing, heavily compressing operating margins and driving free cash flow below historical norms.
كيف يمكن أن تفشل هذه الأطروحة
GLP-1 Widespread Adoption
· Medium
Mass adoption of appetite-suppressing GLP-1 drugs permanently reduces per-capita consumption of high-calorie snacks and sugary beverages, breaking historical volume baselines.
FV impact
-25%
Trigger
3-5 years
Total Loss of Pricing Power
· Low
Consumer fatigue over successive price hikes forces aggressive discounting and promotional activity to defend market share against private label brands, destroying gross margins.
FV impact
-20%
Trigger
1-2 years
Supply Chain and Input Cost Shock
· Medium
Extreme agricultural commodity inflation and localized supply chain disruptions structurally elevate the cost base beyond what can be passed to consumers, permanently compressing operating margins.
FV impact
-15%
Trigger
1-3 years
إشارات الإنذار المبكر للمراقبة
المقياس
الحالي
حد التشغيل
Consecutive quarters of negative organic volume growth.
Based on our latest analysis, PEP looks modestly undervalued. The current price is $155 versus a composite fair-value midpoint of $174 (range $143–$206), which implies roughly 12.8% upside to the midpoint.
Our composite fair-value range for PEP is $143–$206, with a midpoint of $174. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for PepsiCo Inc.'s archetype.
Our current rating for PEP is Buy with a confidence score of 88/100. PEP is rated Buy at $154.62 versus the reconciled fair value midpoint of $174.41, implying +12.80% upside/downside. Confidence is separately disclosed at 88/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for PepsiCo Inc. are: GLP-1 Widespread Adoption; Total Loss of Pricing Power; Supply Chain and Input Cost Shock. The single biggest risk is Multiple cross-checks confirm the prolonged terminal value driven by deep distribution moats.
Our current rating for PEP is Buy, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($143–$206) versus the current price of $155.
PepsiCo Inc. is classified as a mature-dividend stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for PEP.
